Sun, Dec 28, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Alternative Market Briefing

Jabre’s Global Balanced fund loses 27% in 2011

Friday, January 13, 2012

Benedicte Gravrand, Opalesque Geneva: One of the hedge funds run by Jabre Capital Partners, a firm in Geneva which manages around $3bn in AuM, lost around a quarter if its capital in 2011, reports Swiss daily Le Temps. The money apparently went in trading losses but also in redemptions.

The fund, JabCap Global Balanced, now manages around $628m, says Bloomberg, and NAV dived from $183 on 31st December 2010 to $133 on 30th December 2011. This was confirmed by Investment Europe, which said that former top-performing Jabcap Balanced Fund had posted -26.88% for 2011.

Philippe Jabre’s Cayman domiciled-fund gained 20% in 2007, 2% in 2008, 45% in 2009 and almost 4% in 2010. Some commentators said its 2011 losses were caused by wrong bets – much of which in Japan – amplified by derivatives. "We should have seen the economic slowdown in H2 and should have covered our investments, rather than risk it with futures," a Jabre associate told Le Temps.

Jabre bought long Japanese stocks on news of the 2011 Japan earthquake, and then suffered when the Nikkei Stock Average tumbled 13%. Then he sold his shares in late March, just before a rebound in Japanese stocks, costing his firm about $300m, ......................

To view our full article Click here

Today's Exclusives Today's Other Voices More Exclusives
Previous Opalesque Exclusives                                  
More Other Voices
Previous Other Voices                                               
Access Alternative Market Briefing


  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Hong Kong-Shanghai stock link fails to live up to expectation so far[more]

    Komfie Manalo, Opalesque Asia: In a report, Reuters said that demand has been subdued with the bulk of activities coming from short-term speculative investors. Las

  2. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  3. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  4. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for

  5. CFTC Revokes Registrations of Illinois Resident Aleks A. Kins and Chicago-based AlphaMetrix, LLC[more]

    Matthias Knab, Opalesque: The U.S. Commodity Futures Trading Commission (CFTC) today announced that it has revoked the registration of Aleks A. Kins of Chicago, Illinois, as an Associated Person and the registrations of AlphaMetrix, LLC (AlphaMetrix), a Delaware limited liability company with its